Have a personal or library account? Click to login
The role of ultrasonography in methotrexate therapy for ectopic pregnancy Cover

The role of ultrasonography in methotrexate therapy for ectopic pregnancy

By: Piotr Czuczwar  
Open Access
|Aug 2018

References

  1. Lipscomb GH: Medical management of ectopic pregnancy. Clin Obs Gynecol 2012; 55: 424–432.
  2. Cecchino GN, Araujo E Jr, Elito J Jr: Methotrexate for ectopic pregnancy: When and how. Arch Gynecol Obstet 2014; 290: 417–423.
  3. Skubisz MM, Tong S: The evolution of methotrexate as a treatment for ectopic pregnancy and gestational trophoblastic neoplasia: A review. ISRN Obstet Gynecol 2012; 2012: 637094.
  4. Tanaka T, Hayashi H, Kutsuzawa T, Fujimoto S, Ichinoe K: Treatment of interstitial ectopic pregnancy with methotrexate: Report of a successful case. Fertil Steril 1982; 37: 851–852.
  5. Stovall TG, Ling FW, Buster JE: Outpatient chemotherapy of unruptured ectopic pregnancy. Fertil Steril 1989; 51: 435–438.
  6. Stovall TG, Ling FW, Gray LA: Single-dose methotrexate for treatment of ectopic pregnancy. Obstet Gynecol 1991; 77: 754–757.
  7. Stovall TG, Ling FW: Ectopic pregnancy. Diagnostic and therapeutic algorithms minimizing surgical intervention. J Reprod Med 1993; 38: 807–812.
  8. Hajenius PJ, Mol F, Mol BW, Bossuyt PM, Ankum WM, van der Veen F: Interventions for tubal ectopic pregnancy. Cochrane Database Syst Rev 2007; (1): CD000324.
  9. Helmy S, Koch M, Kölbl H, Grohmann-Izay B, Solomayer E, Bader Y: Correlation of the volume of ectopic pregnancy and MTX therapy outcome: A retrospective cohort study. Eur J Obstet Gynecol Reprod Biol 2015; 184: 108–111.
  10. Marret H, Fauconnier A, Dubernard G, Misme H, Lagarce L, Lesavre M et al.: Overview and guidelines of off-label use of methotrexate in ectopic pregnancy: Report by CNGOF. Eur J Obstet Gynecol Reprod Biol 2016; 205: 105–109.
  11. Gnisci A, Stefani L, Bottin P, Ohannessian A, Gamerre M, Agostini A: Predictive value of hemoperitoneum for outcome of methotrexate treatment in ectopic pregnancy: An observational comparative study. Ultrasound Obstet Gynecol 2014; 43: 698–701.
  12. da Costa Soares R, Elito J Jr, Han KK, Camano L: Endometrial thickness as an orienting factor for the medical treatment of unruptured tubal pregnancy. Acta Obstet Gynecol Scand 2004; 83: 289–292.
  13. Takacs P, Chakhtoura N, De Santis T, Verma U: Evaluation of the relationship between endometrial thickness and failure of single-dose methotrexate in ectopic pregnancy. Arch Gynecol Obstet 2005; 272: 269–272.
  14. Elito J Jr, Reichmann AP, Uchiyama MN, Camano L: Predictive score for the systemic treatment of unruptured ectopic pregnancy with a single dose of methotrexate. Int J Gynaecol Obstet 1999; 67: 75–79.
  15. Atri M, Bret PM, Tulandi T, Senterman MK: Ectopic pregnancy: Evolution after treatment with transvaginal methotrexate. Radiology 1992; 185: 749–753.
  16. Gamzu R, Almog B, Levin Y, Pauzner D, Lessing JB, Jaffa A et al.: The ultrasonographic appearance of tubal pregnancy in patients treated with methotrexate. Hum Reprod 2002; 17: 2585–2587.
  17. Desai A, Fleischer AC, Wahab SA, New M, Smolinsky C, McKenna J et al.: Sonography of responsive versus nonresponsive ectopic pregnancies. J Ultrasound Med 2016; 35: 1341–1347.
DOI: https://doi.org/10.15557/jou.2018.0023 | Journal eISSN: 2451-070X | Journal ISSN: 2084-8404
Language: English
Page range: 158 - 161
Submitted on: Nov 13, 2017
|
Accepted on: Jun 29, 2018
|
Published on: Aug 31, 2018
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2018 Piotr Czuczwar, published by MEDICAL COMMUNICATIONS Sp. z o.o.
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.